Evaluating cannabis extract for fibromyalgia symptoms
Official title: ObServational StUdy of CaNnabis ExtRact in FIbromyalgia SyndromE
Run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT06747039 · Data updated 2026-11-12
This study is testing if a cannabis extract can help people with fibromyalgia feel less pain and improve their overall quality of life over 12 weeks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 38 (estimated) |
| Sponsor | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Academic / other |
| Locations | 1 site (Milan, Milano) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | September 2025 |
| Study ends | December 2025 |
| Registry record updated | December 24, 2024 |
| Trial ID | NCT06747039 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a diagnosis of fibromyalgia who have not found relief from first- or second-line treatments.
✕Probably not a fit
Patients with fibromyalgia who are currently stable on other pain management therapies or those with psychiatric diagnoses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the effects of the cannabis extract Avextra 10/10 solution on pain, fatigue, sleep, and quality of life in patients diagnosed with fibromyalgia syndrome. Participants will complete surveys regarding their symptoms at baseline, and then again at 4, 8, and 12 weeks after starting the treatment. The primary focus is to determine if the cannabis extract can significantly reduce pain after 12 weeks of use. Secondary objectives include evaluating its impact on fatigue, sleep, anxiety, and depression over the same period.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option for managing fibromyalgia symptoms, potentially improving patients' quality of life.
How similar studies have gone: While cannabis-based treatments for fibromyalgia are gaining attention, this specific approach using Avextra 10/10 is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a diagnosis of FM according to 2016 American College of Rheumatology Criteria. * Patients with FM prescribed cannabis extract Avextra 10/10 solution after failure and/or intolerance of first- or second-line treatment. * Aged 18 years and older. * Able to fully understand and fill questionnaires. * Able to provide informed consent, according to requirements of local IRB/ethics committee. Exclusion Criteria: * Known history of pain not due to FM. * Patients who have not received stable therapy for pain, sleep disorders, or any psychiatric condition for at least 2 weeks. * Patients who are taking other types of medical cannabis besides Avextra 10/10 solution. * Concomitant diagnosis of other pathologies that could interfere with clinical judgment. * Psychiatric diagnosis according to DSM-V-TR * Pregnancy or breastfeeding
Where it's running
-
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Milano, Italy Recruiting
Study contacts
- Principal investigator: Piercarlo Sarzi Puttini, Medical Doctor — IRCCS Ospedale Galeazzi Sant'Ambrogio
- Study coordinator: Greta Pellegrino, Medical Doctor
- Email: greta.pellegrino@grupposandonato.it
- Phone: 0283500010
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Noninvasive brain stimulation to see if it lowers pain in fibromyalgia
This study tests whether daily noninvasive brain stimulation can reduce pain and improve quality of life for people with fibromyalgia, using two brain targets and a crossover design.
-
Home-based high-dose tDCS for fibromyalgia: predicting response and comparing brain targets
This study tests whether a high-dose home-based tDCS treatment is at least as good as the conventional home-based tDCS for people with fibromyalgia, and whether it could be better, while also checking if baseline EEG can predict who responds.
-
Dietary strategies to help fibromyalgia in overweight or obese women
This trial tests whether a very low-calorie ketogenic diet, a Mediterranean diet, or a Mediterranean diet with a probiotic can reduce fibromyalgia symptoms in overweight or obese women.
-
Isokinetic microdose exercise for women with fibromyalgia
This 8-week program will test whether low-dose isokinetic exercise helps women with fibromyalgia reduce pain, improve strength, and enhance quality of life.
-
Does hardaliye help fibromyalgia when added to a personalized diet?
This study tests whether a traditional grape-based drink called hardaliye, used with a personalized diet, can improve symptoms and inflammation in adult women with fibromyalgia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.